|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
6
|
|
gptkbp:bfsParent
|
gptkb:bimatoprost
|
|
gptkbp:activities
|
prostaglandin analog
|
|
gptkbp:appointed_by
|
gptkb:sneaker
|
|
gptkbp:approves
|
gptkb:2001
gptkb:FDA
|
|
gptkbp:brand
|
Travatan
|
|
gptkbp:class
|
antiglaucoma agent
|
|
gptkbp:clinical_trial
|
Phase III
long-term treatment
effective in lowering IOP
|
|
gptkbp:contraindication
|
hypersensitivity to travoprost
|
|
gptkbp:developed_by
|
gptkb:Alcon_Laboratories
|
|
gptkbp:dosage_form
|
gptkb:software_framework
|
|
gptkbp:education
|
instruct on proper use
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:formulation
|
0.004% solution
|
|
gptkbp:frequency
|
once daily
|
|
gptkbp:healthcare
|
gptkb:sneaker
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
travoprost
|
|
gptkbp:indication
|
gptkb:ocular_hypertension
|
|
gptkbp:ingredients
|
gptkb:travoprost
C23 H32 O5
|
|
gptkbp:interacts_with
|
none significant
|
|
gptkbp:invention
|
patented
|
|
gptkbp:is_atype_of
|
S01 E E03
|
|
gptkbp:is_used_for
|
gptkb:sneaker
|
|
gptkbp:lifespan
|
45 minutes
|
|
gptkbp:manager
|
topical
|
|
gptkbp:marketed_as
|
gptkb:Europe
gptkb:United_States
gptkb:Alcon
gptkb:Native_American_tribe
|
|
gptkbp:packaging
|
gptkb:beer
|
|
gptkbp:pharmacokinetics
|
metabolized in the liver
increases aqueous humor outflow
|
|
gptkbp:population
|
gptkb:Person
adults
|
|
gptkbp:previous_name
|
gptkb:battle
|
|
gptkbp:price
|
varies by region
|
|
gptkbp:products
|
gptkb:bimatoprost
gptkb:latanoprost
|
|
gptkbp:provides_information_on
|
recommended for glaucoma management
|
|
gptkbp:requires
|
gptkb:theorem
gptkb:stock_market_index
|
|
gptkbp:research
|
ongoing
|
|
gptkbp:safety_features
|
generally well tolerated
not for use in contact lens wearers
|
|
gptkbp:shelf_life
|
2 years
|
|
gptkbp:side_effect
|
blurred vision
eye irritation
dry eye
conjunctival hyperemia
eyelash growth
increased pigmentation of the iris
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:type_of
|
157283-68-6
|